Dr. Garland serves as Director of the University of Arizona Cancer Center’s Clinical Lung Cancer Program, as well as an Associate Professor of Clinical Medicine. Her research focuses on experimental therapeutics related to malignant diseases of the chest. Dr. Garland specializes in the treatment of mesothelioma, among other diseases.
Her lab is currently designing trials using new chemotherapy agents which can selectively target cancer cells more effectively, providing more potent anticancer activity with less toxicity.
Dr. Garland received her medical degree from the University of Texas in 1988, and completed her residency at the University of South Florida College of Medicine in 1993. She also completed a fellowship at the H. Lee Moffitt Cancer Center in Tampa, Florida, focusing on hematology and oncology.
Dr. Garland is certified by the American Board of Medical Oncology, and has co-authored several journal articles concerning mesothelioma and small-cell lung cancer.